Never begin, stop, change, or switch a GLP-1 medication without guidance from the prescribing provider
The primary ingredient is Poly-L-Lactic Acid (PLLA), which is a biocompatible and biodegradable substance that has been used in medical applications for decades
Food and Drug Administration (FDA) announced the launch of its Green List initiative designed to protect consumers from illegally imported GLP-1 drug ingredientssuch as semaglutide and tirzepatideon September 5, 2025
Pills could attract new patients to seek obesity treatment for the first time, expanding the broader weight loss and diabetes drug market and potentially boosting sales for Novo Nordisk and Eli Lilly
For patients taking a GLP-1 receptor agonist for weight loss , hold the GLP-1 receptor agonist for at least 3 half-lives ahead of the procedure
In addition, adipose tissue, through the secretion of adipokines, plays a central role in immune and metabolic processes